Company / Operating Income per Share
Ligand Pharmaceuticals, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$2.15
FY2025
5-year range
-$1.29 / $6.46
FY2021-FY2025
Trend
+266.7%
vs FY2024
Sector context
#28 of 201
Health Care
What the data says
Operating Income per Share changed +267% YoY in FY2025, a notable deviation from the 9-year average annual change of +95%.
Based on SEC 10-K filings.
2.15 in FY2025 with a 5-year CAGR of -0.8%. Top quartile in the Health Care sector.
Improved from $0.70 to $2.15 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +128.0%
- 5-Year CAGR
- -0.8%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 201This company $2.15 Sector average -$28.56
▼
+107.5% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 266.7% year-over-year.
- Ranks #28 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2019.
- Lowest operating income per share in the period was in FY2024.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.15 | +266.7% |
| FY2024 | -$1.29 | -282.8% |
| FY2023 | $0.70 | +288.9% |
| FY2022 | $0.18 | -97.2% |
| FY2021 | $6.46 | +189.7% |
| FY2020 | $2.23 | -94.3% |
| FY2019 | $38.87 | +402.0% |
| FY2018 | $7.74 | +137.8% |
| FY2017 | $3.26 | +48.0% |
| FY2016 | $2.20 | +57.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026